No insider purchase over the last 90 days. The latest, by 안성현, was filed 15 Jul 2026.
DRTECH Corporation: what insiders have been doing
Every trade that managers of DRTECH Corporation disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. In the past year (2 November 2025 to 2 November 2026), 9 filings came from 7 insiders.
The flow runs one way only: 5 insiders bought (6 purchases totalling €5,735) and nobody sold on the market. The amount is not disclosed for 5 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €5,735, the purchase published on 2 June 2026 by 안성현 is the largest of the period (0.012% of market cap). Those buying include 2 major shareholders, 1 finance chief and 1 chief executive.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 9 filings, this issuer sits above that mark. Since 2021, the database holds 27 purchases and 8 sales by insiders of the company.
The most recent open-market purchase was published on 15 July 2026, 118 days ago. The median gap between a trade and its publication by DART (FSS) is 1 day. Until a filing is published, the market cannot know about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -28.3%Entry ₩1,339 · Close at T+90 ₩960
- -5.7%Entry ₩2,015 · Close at T+90 ₩1,900
- -37.7%Entry ₩3,050 · Close at T+365 ₩1,901
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- ●Executives0DART
- 6,984 sharesShareKRXDART:20260715000025Canonical exit: 13 Oct 2026 (T+90)
- 1,130,501 sharesKRXDART:20260713000249Canonical exit: 11 Oct 2026 (T+90)
- 11,029,412 sharesKRXDART:20260630000342Canonical exit: 28 Sept 2026 (T+90)
- 80,000 sharesShareKRXDART:20260623000013Canonical exit: 21 Sept 2026 (T+90)
- 7,137 shares@ ₩1,419.000.012% mcap100.0% of flowShareKRXDART:20260602000100Canonical exit: 31 Aug 2026 (T+90)
- 0KRXDART:20260430001548
- ●Executives0DART
- 3,738,317 sharesKRXDART:20260105000364Canonical exit: 31 Mar 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20241108000495
- ShareKRXDART:20240725000399Canonical exit: 21 Oct 2024 (T+90)
- 0KRXDART:20240611000459
- 400,000 sharesKRXDART:20240605000511
- ShareKRXDART:20240605000489
- ShareKRXDART:20240605000497
- ShareKRXDART:20240605000485
- ShareKRXDART:20240605000503
- ShareKRXDART:20240605000480
- ShareKRXDART:20240605000493
- 5,591,277 sharesKRXDART:20240528000432
- 9,163,616 sharesKRXDART:20240528000451Canonical exit: 22 Aug 2024 (T+90)
25 of 60 declarations
About DRTECH Corporation
디알텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
